25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ARTL (Artelo Biosciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Artelo Biosciences Inc together

I guess you are interested in Artelo Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Artelo Biosciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Artelo Biosciences Inc’s Price Targets

I'm going to help you getting a better view of Artelo Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Artelo Biosciences Inc

I send you an email if I find something interesting about Artelo Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Artelo Biosciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Artelo Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.20
Expected worth in 1 year
$-2.56
How sure are you?
29.3%

+ What do you gain per year?

Total Gains per Share
$-2.76
Return On Investment
-11.5%

For what price can you sell your share?

Current Price per Share
$23.88
Expected price per share
$10.50 - $
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Artelo Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)
$23.88
Intrinsic Value Per Share
$-69.74 - $127.92
Total Value Per Share
$-69.54 - $128.12

2.2. Growth of Artelo Biosciences Inc (5 min.)




Is Artelo Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$652k$13m-$8.7m-203.7%

How much money is Artelo Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.4m-$2.4m-$27.7k-1.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Artelo Biosciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#738 / 872

Most Revenue
#813 / 872

Most Profit
#316 / 872

Most Efficient
#263 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Artelo Biosciences Inc?

Welcome investor! Artelo Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Artelo Biosciences Inc.

First you should know what it really means to hold a share of Artelo Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Artelo Biosciences Inc is $23.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Artelo Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Artelo Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.20. Based on the TTM, the Book Value Change Per Share is $-0.69 per quarter. Based on the YOY, the Book Value Change Per Share is $-7.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Artelo Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.72-3.0%-0.74-3.1%-2.28-9.6%-2.31-9.7%-2.66-11.1%-1.63-6.8%
Usd Book Value Change Per Share-0.67-2.8%-0.69-2.9%-7.33-30.7%-3.91-16.4%-0.33-1.4%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.67-2.8%-0.69-2.9%-7.33-30.7%-3.91-16.4%-0.33-1.4%0.000.0%
Usd Price Per Share0.88-1.10-1.58-1.64-1.36-1.86-
Price to Earnings Ratio-0.30--0.44--0.27--0.29--0.21--0.39-
Price-to-Total Gains Ratio-1.30--2.01--0.84--1.15--0.57--5.43-
Price to Book Ratio4.40-1.70-0.25-0.67-0.43--0.66-
Price-to-Total Gains Ratio-1.30--2.01--0.84--1.15--0.57--5.43-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share23.875
Number of shares41
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.69-0.33
Usd Total Gains Per Share-0.69-0.33
Gains per Quarter (41 shares)-28.25-13.50
Gains per Year (41 shares)-113.00-53.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-113-1230-54-64
20-226-2360-108-118
30-339-3490-162-172
40-452-4620-216-226
50-565-5750-270-280
60-678-6880-324-334
70-791-8010-378-388
80-904-9140-432-442
90-1017-10270-486-496
100-1130-11400-540-550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.041.00.00.0%0.043.00.00.0%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%12.029.00.029.3%13.030.00.030.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.041.00.0%0.00.043.00.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%12.029.00.029.3%13.030.00.030.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Artelo Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.672-0.689+3%-7.327+990%-3.913+482%-0.329-51%0.005-14860%
Book Value Per Share--0.1991.325-85%15.766-99%18.316-99%20.677-99%10.710-98%
Current Ratio--0.4933.913-87%14.664-97%16.426-97%16.898-97%9.895-95%
Debt To Asset Ratio--0.8150.360+127%0.068+1092%0.154+427%0.115+610%0.773+5%
Debt To Equity Ratio--4.3911.325+232%0.074+5831%0.478+818%0.311+1313%0.498+782%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--7903.0001945896.115-100%8586134.938-100%9826370.378-100%10346133.235-100%8561267.194-100%
Eps---0.723-0.745+3%-2.284+216%-2.312+220%-2.661+268%-1.631+126%
Free Cash Flow Per Share---0.487-0.537+10%-1.998+310%-2.086+329%-2.350+383%-1.609+231%
Free Cash Flow To Equity Per Share---0.487-0.533+10%-2.319+376%-2.190+350%0.730-167%0.466-204%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--127.918----------
Intrinsic Value_10Y_min---69.738----------
Intrinsic Value_1Y_max---3.653----------
Intrinsic Value_1Y_min---8.166----------
Intrinsic Value_3Y_max--1.577----------
Intrinsic Value_3Y_min---23.661----------
Intrinsic Value_5Y_max--21.941----------
Intrinsic Value_5Y_min---38.078----------
Market Cap13051674.625+78%2870903.0003572396.115-20%2781884.938+3%2527037.045+14%1721553.085+67%1495001.059+92%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio120.145+96%4.4031.695+160%0.251+1657%0.669+558%0.430+924%-0.662+115%
Pe Ratio-8.256-2629%-0.303-0.444+47%-0.274-9%-0.290-4%-0.208-31%-0.385+27%
Price Per Share23.875+96%0.8751.099-20%1.583-45%1.642-47%1.361-36%1.862-53%
Price To Free Cash Flow Ratio-12.263-2629%-0.449-0.619+38%-0.279-38%-0.350-22%-0.249-45%-0.415-8%
Price To Total Gains Ratio-35.526-2629%-1.302-2.013+55%-0.838-36%-1.152-12%-0.573-56%-5.429+317%
Quick Ratio---1.435-100%19.195-100%22.011-100%21.849-100%12.279-100%
Return On Assets---0.675-0.482-29%-0.182-73%-0.262-61%-0.222-67%-0.671-1%
Return On Equity---3.638-1.368-62%-0.197-95%-0.564-85%-0.407-89%-0.921-75%
Total Gains Per Share---0.672-0.689+3%-7.327+990%-3.913+482%-0.329-51%0.005-14860%
Usd Book Value--652000.0004292250.000-85%13033750.000-95%12673833.333-95%12900003.600-95%6633471.244-90%
Usd Book Value Change Per Share---0.672-0.689+3%-7.327+990%-3.913+482%-0.329-51%0.005-14860%
Usd Book Value Per Share--0.1991.325-85%15.766-99%18.316-99%20.677-99%10.710-98%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--7903.0001945896.115-100%8586134.938-100%9826370.378-100%10346133.235-100%8561267.194-100%
Usd Eps---0.723-0.745+3%-2.284+216%-2.312+220%-2.661+268%-1.631+126%
Usd Free Cash Flow---1597000.000-1751250.000+10%-2240750.000+40%-2009083.333+26%-1806054.600+13%-1090840.220-32%
Usd Free Cash Flow Per Share---0.487-0.537+10%-1.998+310%-2.086+329%-2.350+383%-1.609+231%
Usd Free Cash Flow To Equity Per Share---0.487-0.533+10%-2.319+376%-2.190+350%0.730-167%0.466-204%
Usd Market Cap13051674.625+78%2870903.0003572396.115-20%2781884.938+3%2527037.045+14%1721553.085+67%1495001.059+92%
Usd Price Per Share23.875+96%0.8751.099-20%1.583-45%1.642-47%1.361-36%1.862-53%
Usd Profit---2372000.000-2428750.000+2%-2401000.000+1%-2467083.333+4%-2176668.750-8%-1239797.073-48%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.672-0.689+3%-7.327+990%-3.913+482%-0.329-51%0.005-14860%
 EOD+5 -3MRQTTM+14 -17YOY+17 -143Y+17 -145Y+10 -2110Y+9 -22

3.3 Fundamental Score

Let's check the fundamental score of Artelo Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.256
Price to Book Ratio (EOD)Between0-1120.145
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.493
Debt to Asset Ratio (MRQ)Less than10.815
Debt to Equity Ratio (MRQ)Less than14.391
Return on Equity (MRQ)Greater than0.15-3.638
Return on Assets (MRQ)Greater than0.05-0.675
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Artelo Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.068
Ma 20Greater thanMa 5010.915
Ma 50Greater thanMa 1008.048
Ma 100Greater thanMa 2007.004
OpenGreater thanClose26.920
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Artelo Biosciences Inc

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated/ weight loss with cancer; and ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, pain and inflammation, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Fundamental data was last updated by Penke on 2025-07-10 21:10:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Artelo Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Artelo Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--91.7%+91.7%
TTM--140.3%+140.3%
YOY--196.4%+196.4%
3Y--247.9%+247.9%
5Y--343.3%+343.3%
10Y--488.1%+488.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Artelo Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • -67.5% Return on Assets means thatΒ Artelo Biosciences Inc generatedΒ $-0.67 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Artelo Biosciences Inc:

  • The MRQ is -67.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -48.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-67.5%TTM-48.2%-19.2%
TTM-48.2%YOY-18.2%-30.0%
TTM-48.2%5Y-22.2%-26.1%
5Y-22.2%10Y-67.1%+44.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.5%-11.5%-56.0%
TTM-48.2%-11.5%-36.7%
YOY-18.2%-11.4%-6.8%
3Y-26.2%-11.7%-14.5%
5Y-22.2%-11.9%-10.3%
10Y-67.1%-13.7%-53.4%
4.3.1.3. Return on Equity

Shows how efficient Artelo Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • -363.8% Return on Equity means Artelo Biosciences Inc generated $-3.64Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Artelo Biosciences Inc:

  • The MRQ is -363.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -136.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-363.8%TTM-136.8%-227.0%
TTM-136.8%YOY-19.7%-117.1%
TTM-136.8%5Y-40.7%-96.1%
5Y-40.7%10Y-92.1%+51.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-363.8%-13.6%-350.2%
TTM-136.8%-14.8%-122.0%
YOY-19.7%-14.4%-5.3%
3Y-56.4%-16.8%-39.6%
5Y-40.7%-17.5%-23.2%
10Y-92.1%-19.5%-72.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Artelo Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Artelo Biosciences Inc is operatingΒ .

  • Measures how much profit Artelo Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Artelo Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--221.8%+221.8%
TTM--250.7%+250.7%
YOY--208.5%+208.5%
3Y--220.2%+220.2%
5Y--342.4%+342.4%
10Y--462.5%+462.5%
4.3.2.2. Operating Ratio

Measures how efficient Artelo Biosciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Artelo Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.097-2.097
TTM-2.684-2.684
YOY-3.076-3.076
3Y-3.524-3.524
5Y-4.724-4.724
10Y-6.445-6.445
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Artelo Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Artelo Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.49Β means the company has $0.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Artelo Biosciences Inc:

  • The MRQ is 0.493. The company is unable to pay all its short-term debts. -2
  • The TTM is 3.913. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ0.493TTM3.913-3.420
TTM3.913YOY14.664-10.751
TTM3.9135Y16.898-12.985
5Y16.89810Y9.895+7.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4933.638-3.145
TTM3.9133.846+0.067
YOY14.6644.140+10.524
3Y16.4264.688+11.738
5Y16.8985.722+11.176
10Y9.8956.144+3.751
4.4.3.2. Quick Ratio

Measures if Artelo Biosciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Artelo Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.435-1.435
TTM1.435YOY19.195-17.760
TTM1.4355Y21.849-20.415
5Y21.84910Y12.279+9.571
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.826-2.826
TTM1.4353.116-1.681
YOY19.1953.786+15.409
3Y22.0114.311+17.700
5Y21.8495.702+16.147
10Y12.2796.335+5.944
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Artelo Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Artelo Biosciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Artelo Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.81Β means that Artelo Biosciences Inc assets areΒ financed with 81.5% credit (debt) and the remaining percentage (100% - 81.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Artelo Biosciences Inc:

  • The MRQ is 0.815. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.360. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.815TTM0.360+0.455
TTM0.360YOY0.068+0.291
TTM0.3605Y0.115+0.245
5Y0.11510Y0.773-0.658
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8150.327+0.488
TTM0.3600.349+0.011
YOY0.0680.332-0.264
3Y0.1540.340-0.186
5Y0.1150.346-0.231
10Y0.7730.378+0.395
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Artelo Biosciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 439.1% means that company has $4.39 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Artelo Biosciences Inc:

  • The MRQ is 4.391. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.325. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ4.391TTM1.325+3.067
TTM1.325YOY0.074+1.250
TTM1.3255Y0.311+1.014
5Y0.31110Y0.498-0.187
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3910.383+4.008
TTM1.3250.438+0.887
YOY0.0740.414-0.340
3Y0.4780.450+0.028
5Y0.3110.457-0.146
10Y0.4980.512-0.014
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Artelo Biosciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Artelo Biosciences Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -0.30 means the investor is paying $-0.30Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Artelo Biosciences Inc:

  • The EOD is -8.256. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.303. Based on the earnings, the company is expensive. -2
  • The TTM is -0.444. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.256MRQ-0.303-7.954
MRQ-0.303TTM-0.444+0.141
TTM-0.444YOY-0.274-0.170
TTM-0.4445Y-0.208-0.236
5Y-0.20810Y-0.385+0.177
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.256-2.399-5.857
MRQ-0.303-2.092+1.789
TTM-0.444-2.625+2.181
YOY-0.274-3.784+3.510
3Y-0.290-3.762+3.472
5Y-0.208-6.363+6.155
10Y-0.385-7.055+6.670
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Artelo Biosciences Inc:

  • The EOD is -12.263. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.449. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.619. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.263MRQ-0.449-11.813
MRQ-0.449TTM-0.619+0.169
TTM-0.619YOY-0.279-0.340
TTM-0.6195Y-0.249-0.370
5Y-0.24910Y-0.415+0.166
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.263-3.299-8.964
MRQ-0.449-2.742+2.293
TTM-0.619-3.801+3.182
YOY-0.279-4.402+4.123
3Y-0.350-5.140+4.790
5Y-0.249-8.483+8.234
10Y-0.415-9.296+8.881
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Artelo Biosciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 4.40 means the investor is paying $4.40Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Artelo Biosciences Inc:

  • The EOD is 120.145. Based on the equity, the company is expensive. -2
  • The MRQ is 4.403. Based on the equity, the company is fair priced.
  • The TTM is 1.695. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD120.145MRQ4.403+115.742
MRQ4.403TTM1.695+2.708
TTM1.695YOY0.251+1.445
TTM1.6955Y0.430+1.265
5Y0.43010Y-0.662+1.092
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD120.1452.113+118.032
MRQ4.4031.856+2.547
TTM1.6952.125-0.430
YOY0.2512.454-2.203
3Y0.6692.492-1.823
5Y0.4303.668-3.238
10Y-0.6624.364-5.026
4.6.2. Total Gains per Share

2.4. Latest News of Artelo Biosciences Inc

Does Artelo Biosciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Artelo Biosciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-11
22:52
Artelo Biosciences completes reverse stock split and reports preliminary Q2 financialsRead
2025-07-09
15:02
Artelo Biosciences stock soars after positive preclinical pain dataRead
2025-07-09
13:57
Artelo Biosciences presents positive data for arthritis pain drugRead
2025-07-09
13:50
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society SymposiumRead
2025-07-08
13:57
Artelo stock rating upgraded to Buy by D. Boral Capital on pipeline potentialRead
2025-06-30
22:35
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%Read
2025-06-30
21:24
Artelo Biosciences stock soars after positive first-in-human study resultsRead
2025-06-30
19:49
Sector Update: Health Care Stocks Advance Monday AfternoonRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Artelo Biosciences Inc.

4.8.1. Institutions holding Artelo Biosciences Inc

Institutions are holding 2.639% of the shares of Artelo Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Geode Capital Management, LLC0.8157026762941254.2478
2025-03-31Citadel Advisors Llc0.692022706227060
2025-03-31Susquehanna International Group, LLP0.6214020388203880
2025-03-31UBS Group AG0.3893012772-525-3.9483
2025-03-31Tower Research Capital LLC0.1190.00013903852.2263
2025-03-31Bank of America Corp0.000802713.8462
2025-03-31Morgan Stanley - Brokerage Accounts0.000602000
2025-03-31Rothschild Investment, LLC0.00020800
2024-12-31Northern Trust Investments N A000-834-100
Total 2.6390.000186586+51233+59.2%

4.9.2. Funds holding Artelo Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Spartan Extended Market Index Pool F2.11950.000969542695420
2025-04-30Fidelity Extended Market Index0.58540.000119208-112-0.5797
2025-04-30Fidelity Series Total Market Index0.12770418900
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.10160.0001333400
2025-04-30Fidelity Nasdaq Composite Index0.09910325300
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07910.00012595-47-1.779
2025-03-31NT Ext Equity Mkt Idx Fd - L0.05580183200
2025-03-31Northern Trust Extended Eq Market Idx0.05580183200
2025-05-31State St US Extended Mkt Indx NL Cl C0.0211069300
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0134044030.6865
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.013304374370
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.013304374370
2025-03-31SSgA U.S. Total Market Index Strategy0.0088029062.1127
Total 3.29390.0012108082+70266+65.0%

5.3. Insider Transactions

Insiders are holding 0.815% of the shares of Artelo Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-11Gregory D GorgasBUY20024.18
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Working Capital  7,467-2,2395,228-9394,289-3,504785-2,207-1,422



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,515
Total Liabilities2,863
Total Stockholder Equity652
 As reported
Total Liabilities 2,863
Total Stockholder Equity+ 652
Total Assets = 3,515

Assets

Total Assets3,515
Total Current Assets1,382
Long-term Assets2,133
Total Current Assets
Cash And Cash Equivalents 746
Other Current Assets 212
Total Current Assets  (as reported)1,382
Total Current Assets  (calculated)958
+/- 424
Long-term Assets
Property Plant Equipment 91
Intangible Assets 2,039
Long-term Assets Other 3
Long-term Assets  (as reported)2,133
Long-term Assets  (calculated)2,133
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,804
Long-term Liabilities59
Total Stockholder Equity652
Total Current Liabilities
Accounts payable 2,509
Total Current Liabilities  (as reported)2,804
Total Current Liabilities  (calculated)2,509
+/- 295
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt95
Long-term Liabilities  (as reported)59
Long-term Liabilities  (calculated)95
+/- 36
Total Stockholder Equity
Total Stockholder Equity (as reported)652
Total Stockholder Equity (calculated)0
+/- 652
Other
Capital Stock3
Common Stock Shares Outstanding 3,281
Net Invested Capital 652
Net Working Capital -1,422
Property Plant and Equipment Gross 91



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-08-312015-06-302015-03-312014-09-302014-06-302014-03-312013-12-31
> Total Assets 
0
0
15
14
8
13
17
17
4
4
4
4
4
13
228
574
430
541
401
397
165
484
1,153
6,483
5,548
4,152
3,494
4,377
9,539
13,445
12,340
12,635
28,251
26,704
24,405
22,415
20,424
18,478
16,877
15,499
13,043
10,354
8,326
7,136
4,698
3,515
3,5154,6987,1368,32610,35413,04315,49916,87718,47820,42422,41524,40526,70428,25112,63512,34013,4459,5394,3773,4944,1525,5486,4831,15348416539740154143057422813444441717138141500
   > Total Current Assets 
0
0
15
14
8
13
17
17
4
4
4
4
4
13
228
574
429
540
400
396
165
484
1,152
4,443
3,508
2,111
1,453
2,337
7,500
11,405
10,300
10,317
24,609
24,589
22,282
20,303
18,322
16,386
14,602
13,428
10,980
8,188
6,168
4,986
2,557
1,382
1,3822,5574,9866,1688,18810,98013,42814,60216,38618,32220,30322,28224,58924,60910,31710,30011,4057,5002,3371,4532,1113,5084,4431,15248416539640054042957422813444441717138141500
       Cash And Cash Equivalents 
0
0
15
14
8
13
17
17
4
4
4
4
4
11
228
573
412
525
326
337
115
457
286
4,424
3,375
1,983
1,279
2,142
7,389
10,706
10,052
6,629
12,162
10,350
12,122
7,136
6,888
6,916
5,719
2,639
2,815
1,195
881
4,357
2,338
746
7462,3384,3578811,1952,8152,6395,7196,9166,8887,13612,12210,35012,1626,62910,05210,7067,3892,1421,2791,9833,3754,42428645711533732652541257322811444441717138141500
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
541
2
0
0
0
0
0
512
0
3,436
11,951
13,161
9,200
12,347
10,645
8,567
8,272
10,225
7,611
6,414
4,721
500
0
0
005004,7216,4147,61110,2258,2728,56710,64512,3479,20013,16111,9513,43605120000025410000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
16
22
3
9
7
9
46
30
0
0
0
0
0
0
0
1,999
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,9990000000304697932216110000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
2
16
14
58
37
46
18
859
10
88
99
173
195
111
187
248
252
514
3,077
2,949
2,308
789
903
611
10,789
554
579
566
129
219
212
21221912956657955410,7896119037892,3082,9493,0775142522481871111951739988108591846375814162030000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
1
2,040
2,040
2,041
2,041
2,040
2,040
2,040
2,039
2,318
3,642
2,115
2,123
2,112
2,102
2,092
2,275
2,068
2,063
2,166
2,158
2,150
2,141
2,133
2,1332,1412,1502,1582,1662,0632,0682,2752,0922,1022,1122,1232,1153,6422,3182,0392,0402,0402,0402,0412,0412,0402,04010011110000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
0
1
1
1
2
1
0
0
0
0
90
81
73
81
70
60
50
39
29
21
124
116
108
99
91
9199108116124212939506070817381900000121110011110000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,524
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,52400000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,039
2,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,0392,03900000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189
3
3
3
3
0
0
197
3
0
0
0
0
0
0
00000031970033331890000000000000000000000000000000
> Total Liabilities 
0
0
0
2
2
0
2
2
3
8
13
17
10
33
342
29
136
156
492
532
641
1,176
1,019
1,022
585
444
268
502
486
589
424
593
1,084
924
567
512
1,021
840
609
921
1,291
817
1,027
775
1,841
2,863
2,8631,8417751,0278171,2919216098401,0215125679241,0845934245894865022684445851,0221,0191,17664153249215613629342331017138322022000
   > Total Current Liabilities 
0
0
0
2
2
0
2
2
3
8
13
17
10
33
342
29
136
156
492
532
641
1,176
1,019
1,022
585
444
268
502
486
589
424
526
1,027
875
527
480
998
825
603
921
1,291
721
940
697
1,772
2,804
2,8041,7726979407211,2919216038259984805278751,0275264245894865022684445851,0221,0191,17664153249215613629342331017138322022000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
30
30
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
28
31
32
45
42
40
37
34
32
0
0
0
0
0
0
000000323437404245323128000000000000022030300000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000220000000000000000
       Accounts payable 
0
0
0
2
0
0
0
0
3
7
9
13
10
2
303
29
134
154
490
529
635
586
912
349
575
432
256
490
474
584
419
493
975
800
432
411
905
701
523
840
1,238
607
863
627
1,679
2,509
2,5091,6796278636071,238840523701905411432800975493419584474490256432575349912586635529490154134293032101397300002000
       Other Current Liabilities 
0
0
0
-2
2
0
2
2
-2
-7
-4
-8
-10
-1
-294
-28
-132
-153
-487
-527
-629
4
-806
324
-565
-420
-243
-478
-463
-579
-414
-488
-954
-757
-382
-384
-852
-614
46
-791
0
0
0
0
-3
0
0-30000-79146-614-852-384-382-757-954-488-414-579-463-478-243-420-565324-8064-629-527-487-153-132-28-294-1-10-8-4-7-22202-2000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
3
7
9
13
10
32
333
29
134
154
490
529
635
586
912
349
575
432
256
490
474
584
419
67
57
49
40
32
23
15
6
0
0
96
87
78
69
59
5969788796006152332404957674195844744902564325753499125866355294901541342933332101397300000000
> Total Stockholder Equity
0
0
15
13
7
13
15
15
1
-4
-9
-14
-6
-19
-114
545
294
385
-91
-135
-475
-692
134
5,461
4,963
3,708
3,225
3,875
9,054
12,856
11,916
12,042
27,167
25,780
23,838
21,903
19,403
17,638
16,268
14,578
11,752
9,537
7,299
6,361
2,857
652
6522,8576,3617,2999,53711,75214,57816,26817,63819,40321,90323,83825,78027,16712,04211,91612,8569,0543,8753,2253,7084,9635,461134-692-475-135-91385294545-114-19-6-14-9-411515137131500
   Common Stock
0
0
6
6
6
7
8
8
8
8
8
8
8
8
10
11
11
12
13
14
14
16
2
3
3
3
4
5
15
22
23
25
42
42
42
3
3
3
3
3
0
0
0
0
0
0
0000003333342424225232215543332161414131211111088888888766600
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
-2
-12
-12
-7
-11
-10
-10
7
16
51
64
48
48
49
18
-18
-64
-176
-388
-254
-205
-201
-199
0
0
0
0
0
0
000000-199-201-205-254-388-176-64-18184948486451167-10-10-11-7-12-12-201000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,713
2,923
4,108
10,278
11,071
11,176
11,609
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000011,60911,17611,07110,2784,1082,9232,71300000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
24
24
24
32
38
38
39
39
39
39
56
56
56
828
855
1,587
1,869
2,502
3,203
3,616
4,108
10,278
11,071
11,176
11,609
13,272
19,891
25,574
26,859
28,902
48,081
48,705
49,324
49,970
50,675
51,029
51,254
52,011
0
0
0
0
0
0
00000052,01151,25451,02950,67549,97049,32448,70548,08128,90226,85925,57419,89113,27211,60911,17611,07110,2784,1083,6163,2032,5021,8691,5878558285656563939393938383224242400



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-10,108
Operating Income-10,108-10,108
 
Operating Expense (+$)
Research Development5,993
Selling General Administrative4,115
Selling And Marketing Expenses0
Operating Expense10,10810,108
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-10,108
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,826-10,390
EBIT - interestExpense = 0
-9,826
-9,826
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-9,826
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-9,826
Tax Provision-0
Net Income From Continuing Ops-9,826-9,826
Net Income-9,826
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net2820
 

Technical Analysis of Artelo Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Artelo Biosciences Inc. The general trend of Artelo Biosciences Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Artelo Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Artelo Biosciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Artelo Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 25.58 > 10.68 > 10.50.

Know someone who trades $ARTL? Share this with them.πŸ‘‡

Artelo Biosciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Artelo Biosciences Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Artelo Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Artelo Biosciences Inc. The current macd is 4.1396968.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Artelo Biosciences Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Artelo Biosciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Artelo Biosciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Artelo Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartArtelo Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Artelo Biosciences Inc. The current adx is 52.62.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Artelo Biosciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Artelo Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Artelo Biosciences Inc. The current sar is 13.03.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Artelo Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Artelo Biosciences Inc. The current rsi is 72.07. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Artelo Biosciences Inc Daily Relative Strength Index (RSI) ChartArtelo Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Artelo Biosciences Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Artelo Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Artelo Biosciences Inc Daily Stochastic Oscillator ChartArtelo Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Artelo Biosciences Inc. The current cci is 173.12.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Artelo Biosciences Inc Daily Commodity Channel Index (CCI) ChartArtelo Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Artelo Biosciences Inc. The current cmo is 43.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Artelo Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartArtelo Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Artelo Biosciences Inc. The current willr is -20.68739054.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Artelo Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Artelo Biosciences Inc Daily Williams %R ChartArtelo Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Artelo Biosciences Inc.

Artelo Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Artelo Biosciences Inc. The current atr is 3.83020047.

Artelo Biosciences Inc Daily Average True Range (ATR) ChartArtelo Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Artelo Biosciences Inc. The current obv is 38,977,046.

Artelo Biosciences Inc Daily On-Balance Volume (OBV) ChartArtelo Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Artelo Biosciences Inc. The current mfi is 97.62.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Artelo Biosciences Inc Daily Money Flow Index (MFI) ChartArtelo Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Artelo Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Artelo Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Artelo Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5072.068
Ma 20Greater thanMa 5010.915
Ma 50Greater thanMa 1008.048
Ma 100Greater thanMa 2007.004
OpenGreater thanClose26.920
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Artelo Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Artelo Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Artelo Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Artelo Biosciences Inc

I send you an email if I find something interesting about Artelo Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Artelo Biosciences Inc.

Receive notifications about Artelo Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.